The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
We’re investing £56 million into radiotherapy research that will be carried out by a network of specialist institutes across the UK.
The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.
Our scientists are working to improve brain tumour diagnosis. Find out how this could make treatment more personal, and guide people onto clinical trials.
New research has shown that an intelligent knife can distinguish between ovarian cancer and normal tissue. Could it help make ovarian cancer surgery smarter?